These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18182911)

  • 21. Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic?
    Nonnemaker J; Engelen M; Shive D
    Health Econ; 2011 May; 20(5):519-31. PubMed ID: 21433216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of burns in young children from Mexico treated at a U.S. hospital.
    Patel DD; Rosenberg L; Rosenberg M; Leal J; Andersen CR; Foncerrada G; Lee JO; Jimenez CJ; Branski L; Meyer WJ; Herndon DN
    Burns; 2016 Dec; 42(8):1825-1830. PubMed ID: 27576931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slightly hypertonic saline and dextran-40 in resuscitation of methamphetamine burn patients.
    Juern J; Peltier G; Twomey J
    J Burn Care Res; 2008; 29(2):319-22. PubMed ID: 18354288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of commercially available meth-deterrent pseudoephedrine hydrochloride products.
    Rahman Z; Aqueel MS; Korang-Yeboah M; Zidan AS; Chen J; Alayoubi AY; Cruz CN; Ashraf M
    Int J Pharm; 2020 Feb; 575():118909. PubMed ID: 31811923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burns in mobile home fires--descriptive study at a regional burn center.
    Mullins RF; Alarm B; Huq Mian MA; Samples JM; Friedman BC; Shaver JR; Brandigi C; Hassan Z
    J Burn Care Res; 2009; 30(4):694-9. PubMed ID: 19506502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coping with meth lab hazards.
    Betsinger G
    Occup Health Saf; 2006 Nov; 75(11):50, 52, 54-8, passim. PubMed ID: 17125087
    [No Abstract]   [Full Text] [Related]  

  • 27. Estimating the national cost burden from burns resulting from methamphetamine manufacturing.
    Myers J; Lehna C
    J Burn Care Res; 2015; 36(3):e226-7. PubMed ID: 25942649
    [No Abstract]   [Full Text] [Related]  

  • 28. The methamphetamine burn patient.
    Warner P; Connolly JP; Gibran NS; Heimbach DM; Engrav LH
    J Burn Care Rehabil; 2003; 24(5):275-8. PubMed ID: 14501394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute public health consequences of methamphetamine laboratories--16 states, January 2000-June 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(14):356-9. PubMed ID: 15829865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Problems of the use of pseudoephedrine by athletes.
    Pokrywka A; Tszyrsznic W; Kwiatkowska DJ
    Int J Sports Med; 2009 Aug; 30(8):569-72. PubMed ID: 19382058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recoveries of trace pseudoephedrine and methamphetamine residues from impermeable household surfaces: implications for sampling methods used during remediation of clandestine methamphetamine laboratories.
    Abdullah AF; Miskelly GM
    Talanta; 2010 Apr; 81(1-2):455-61. PubMed ID: 20188946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burns in Israel, comparative study: Demographic, etiologic and clinical trends 1997-2003 vs. 2004-2010.
    Harats M; Peleg K; Givon A; Kornhaber R; Goder M; Jaeger M; Haik J
    Burns; 2016 May; 42(3):500-7. PubMed ID: 26410362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population-based assessment of burn injury in southern Iowa: identification of children and young-adult at-risk groups and behaviors.
    Wibbenmeyer LA; Amelon MJ; Torner JC; Kealey GP; de Mola RM; Lundell J; Lynch CF; Aspelund T; Zwerling C
    J Burn Care Rehabil; 2003; 24(4):192-202. PubMed ID: 14501412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resurgence of methamphetamine related burns and injuries: a follow-up study.
    Davidson SB; Blostein PA; Walsh J; Maltz SB; Elian A; VandenBerg SL
    Burns; 2013 Feb; 39(1):119-25. PubMed ID: 22541621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacists on the front lines in the fight against meth. A 50-state comparison of the laws regulating the retail sale of pseudoephedrine.
    Rigdon BA
    J Leg Med; 2012 Apr; 33(2):253-83. PubMed ID: 22694096
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysing pseudoephedrine/methamphetamine policy options in Australia using multi-criteria decision modelling.
    Manning M; Wong GT; Ransley J; Smith C
    Int J Drug Policy; 2016 Jun; 32():85-92. PubMed ID: 27179610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Mississippi's prescription-only precursor control law a prescription to decrease the production and raise the price of methamphetamine?
    Cunningham S; Finlay K; Stoecker C
    Int J Drug Policy; 2015 Nov; 26(11):1144-9. PubMed ID: 26187186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population-based study of the epidemiology of acute adult burn injuries in the Calgary Health Region and factors associated with mortality and hospital length of stay from 1995 to 2004.
    Burton KR; Sharma VK; Harrop R; Lindsay R
    Burns; 2009 Jun; 35(4):572-9. PubMed ID: 19203840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular injuries from shake and bake methamphetamine labs.
    Chan AY; Storck SA; Stone DU
    J Okla State Med Assoc; 2011; 104(11-12):409-12. PubMed ID: 22413412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pakistan takes small steps towards tackling burn injuries.
    Burki T
    Lancet; 2016 Oct; 388(10052):1366. PubMed ID: 27707484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.